NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

A Phase I/II Study to Evaluate Single Agent and Combination Therapy With Megestrol Acetate and Dronabinol for the Treatment of HIV-Wasting Syndrome

Phase 1

Completed

Conditions: Cachexia
HIV Infections
HIV Wasting Syndrome

First Posted Date: 2001-08-31

Last Posted Date: 2008-08-25

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 56

Registration Number: NCT00000737

Locations: 🇺🇸
Denver Public Health Dept, Denver, Colorado, United States
🇺🇸
Univ of Illinois, Chicago, Illinois, United States
🇺🇸
Univ of Kansas School of Medicine, Wichita, Kansas, United States

and more 6 locations

A Study of Dideoxycytidine Plus Zidovudine in the Treatment of AIDS or Advanced AIDS Related Complex (ARC)

Phase 1

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2008-08-08

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 68

Registration Number: NCT00000978

Locations: 🇺🇸
Univ of California / San Diego Treatment Ctr, San Diego, California, United States
🇺🇸
Univ of Miami School of Medicine, Miami, Florida, United States

A Pilot Study of Methodology to Rapidly Evaluate Drugs for Bactericidal Activity, Tolerance, and Pharmacokinetics in the Treatment of Pulmonary Tuberculosis Using Isoniazid and Levofloxacin

Phase 1

Completed

Conditions: HIV Infections
Tuberculosis

First Posted Date: 2001-08-31

Last Posted Date: 2008-08-08

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 44

Registration Number: NCT00000778

Locations: 🇺🇸
Tulane Univ Med School, New Orleans, Louisiana, United States
🇺🇸
UCLA Med Ctr, Los Angeles, California, United States
🇺🇸
Harbor - UCLA Med Ctr, Torrance, California, United States

and more 7 locations

A Phase I Study of the Safety and Pharmacokinetics of Recombinant Human CD4-Immunoglobulin G (rCD4-IgG) Administered by Intravenous Bolus Injection in Combination With Oral Zidovudine in Patients With AIDS and AIDS-Related Complex

Phase 1

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2008-08-06

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 40

Registration Number: NCT00000976

Locations: 🇺🇸
Univ of Massachusetts, Worcester, Massachusetts, United States
🇺🇸
Univ of California / San Diego Treatment Ctr, San Diego, California, United States
🇺🇸
Univ of Miami School of Medicine, Miami, Florida, United States

A Randomized Study of Activity, Safety, and Tolerance of Oral Ro 24-7429 (Tat Antagonist) in Patients With HIV Infection

Phase 1

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2008-08-04

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 96

Registration Number: NCT00000760

Locations: 🇺🇸
UCSD, San Diego, California, United States
🇺🇸
Case Western Reserve Univ, Cleveland, Ohio, United States
🇺🇸
Harvard (Massachusetts Gen Hosp), Boston, Massachusetts, United States

and more 1 locations

Safety and Efficacy of Polyethylene Glycolated IL-2 (PEG IL-2) Plus Zidovudine in HIV Positive, Asymptomatic and Symptomatic Individuals

Phase 1

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2008-08-04

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 26

Registration Number: NCT00000664

Locations: 🇺🇸
Stanford Univ School of Medicine, Stanford, California, United States

A Comparison of HIV-Infected Patients With and Without Opportunistic (AIDS-Related) Infection

Completed

Conditions: Cytomegalovirus Infections
Cytomegalovirus Retinitis
Pneumonia, Pneumocystis Carinii
HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2008-08-04

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 90

Registration Number: NCT00005572

Locations: 🇺🇸
Univ of California / San Diego Treatment Ctr, San Diego, California, United States
🇺🇸
San Francisco Gen Hosp, San Francisco, California, United States
🇺🇸
Rush Presbyterian - Saint Luke's Med Ctr, Chicago, Illinois, United States

and more 13 locations

The Pharmacokinetics of Zidovudine and Oxazepam Alone and in Combination in the HIV-Infected Patient

Phase 1

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2008-08-04

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 8

Registration Number: NCT00000661

Locations: 🇺🇸
Palo Alto Veterans Adm Med Ctr / Stanford Univ, Palo Alto, California, United States

A Study to Evaluate the Effects of Anti-HIV Drugs in HIV-Positive Patients Who Also Have Hepatitis C Infection

Completed

Conditions: HIV Infections
Hepatitis C

First Posted Date: 2001-08-31

Last Posted Date: 2008-08-01

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 60

Registration Number: NCT00001117

Locations: 🇺🇸
Harbor UCLA Med Ctr, Torrance, California, United States
🇺🇸
Marin County Specialty Clinic, San Rafael, California, United States
🇺🇸
Emory Univ, Atlanta, Georgia, United States

and more 40 locations

Setting up a Blood Bank for Gene Therapy in HIV-Infected Infants

Terminated

Conditions: HIV Infections
Pregnancy

First Posted Date: 2001-08-31

Last Posted Date: 2008-08-01

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 200

Registration Number: NCT00000917

Locations: 🇺🇸
UCSD Med Ctr / Pediatrics / Clinical Sciences, La Jolla, California, United States
🇺🇸
San Francisco Gen Hosp, San Francisco, California, United States
🇺🇸
Harbor - UCLA Med Ctr / UCLA School of Medicine, Los Angeles, California, United States

and more 5 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy